Subacute sclerosing panencephalitis primary prevention

Subacute sclerosing panencephalitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Subacute sclerosing panencephalitis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Subacute sclerosing panencephalitis primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Subacute sclerosing panencephalitis primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Subacute sclerosing panencephalitis primary prevention
CDC on Subacute sclerosing panencephalitis primary prevention
Subacute sclerosing panencephalitis primary prevention in the news
Blogs on Subacute sclerosing panencephalitis primary prevention
Directions to Hospitals Treating Subacute sclerosing panencephalitis
Risk calculators and risk factors for Subacute sclerosing panencephalitis primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Immunization against measles is the only known prevention for SSPE. The measles vaccine has been highly effective in reducing the numbers of affected children.

Measles immunization should be done according to the recommended American Academy of Pediatrics and Centers for Disease Control schedule.

References

Template:WH Template:WS